Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-09-18
1987-12-08
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514807, 530315, A61K 3734, C07K 716
Patent
active
047118776
ABSTRACT:
Vasopressin derivatives having unexpected VSP site binding activity whose structures are characterized by a Mpr unit at position 1 and a Pen unit at position 6 are prepared by standard peptide synthetic methods also using an oxidative cyclization of a linear peptide dimercaptan. A representative species is [1-.beta.-mercaptopropionic acid-2-(O-ethyl)-D-tyrosine-4-valine-6-penicillamine-8-arginine]vasopressi n.
REFERENCES:
patent: 3497491 (1970-02-01), Zaoral et al.
patent: 4367225 (1983-01-01), Manning et al.
patent: 4469679 (1984-09-01), Huffman et al.
patent: 4469680 (1984-09-01), Huffman et al.
patent: 4481194 (1984-11-01), Ali et al.
patent: 4482486 (1984-11-01), Brtnik et al.
patent: 4491577 (1985-01-01), Manning et al.
patent: 4508645 (1985-04-01), Simek et al.
Chem. Abstr., vol. 88 (1978), 676s.
F. L. Stassen et al., J. Pharmacology and Experimental Therapeutics, 223 53 (1982).
Lourie Alan D.
Phillips Delbert R.
SmithKline Beckman Corporation
Suter Stuart R.
Williams Janice E.
LandOfFree
6-pen-vasopressin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-pen-vasopressin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-pen-vasopressin compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-22749